Rosenblatt Adjusts Price Target on CME Group to $173 From $169, Maintains Sell Rating
Morgan Stanley Adjusts Price Target on CME Group to $210 From $208, Maintains Equalweight Rating
Oppenheimer Adjusts CME Group Price Target to $222 From $221, Maintains Outperform Rating
Rosenblatt Securities Adjusts CME Group Price Target to $169 From $161, Maintains Sell Rating
データなし
データなし